- Q1 FY2027 revenue $1.415B, +6% YoY
- GAAP diluted EPS $2.92, +23% YoY
- Non-GAAP diluted EPS $2.91, +14% YoY
Resmed reported Q1 revenue of $1.415B, up 6% YoY, and GAAP EPS of $2.92, up 23%. Non-GAAP EPS rose 14% to $2.91. The company also declared a quarterly dividend of $0.66 per share.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.